Results 41 to 50 of about 17,623 (223)

Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol [PDF]

open access: yesГинекология, 2020
D-chiroinositol (DCI) is one of the 9 inositol isomers that forms inositol phosphoglycans, which are mediators of the action of insulin. The metabolism of DCI and myo-inositol (MI) is impaired against the background of insulin resistance, including the ...
Olga A. Gromova   +4 more
doaj   +1 more source

Insulin Resistance: An Update on Biochemical and Pathophysiological Mechanisms and Impact on Various Diseases

open access: yesiNew Medicine, EarlyView.
ABSTRACT Insulin resistance is the biological phenomenon in which the human body's normal response to the metabolic hormone insulin is compromised. Insulin is a regulator of most of the essential metabolic steps in the body that control energy homoeostasis, so dysregulation leads to multiple diverse human diseases including, most prominently, Type 2 ...
Peter J. Little   +12 more
wiley   +1 more source

Steroidopathies and hormonal imbalance in children and adolescents with autism spectrum disorder

open access: yesJCPP Advances, EarlyView.
Abstract Background Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a multifactorial etiology, many aspects of which remain unclear. Emerging evidence suggests a potential association between ASD and clinical manifestations resulting from hormonal imbalances, henceforth named “steroidopathies.” The present study aims to ...
Concetta de Giambattista   +5 more
wiley   +1 more source

Population and Diagnostic Characteristics of Polycystic Ovary Syndrome and Hyperandrogenism

open access: yesWomen's Health Reports
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder frequently characterized by hyperandrogenism that presents acute and chronic health risks. International guidelines for the assessment of PCOS endorse Rotterdam criteria for diagnosis,
Crystal Clark Douglas, Juan Ulises Rojo
doaj   +1 more source

Insulin-like growth factor binding protein-1 and insulin in polycystic ovary syndrome: a systematic review and meta-analysis

open access: yesFrontiers in Endocrinology, 2023
BackgroundInsulin-like growth factor binding protein-1 (IGFBP-1) is considered a decline in polycystic ovary syndrome (PCOS), but it remains controversial that whether such reduction is attributed to obesity.AimsThis systematic review aims to explore ...
Yuxin Jin   +13 more
doaj   +1 more source

Psychodermatology of the Female: Hormones, Skin and Mental Health Across the Lifespan

open access: yesJEADV Clinical Practice, EarlyView.
Hormonal transitions across the female lifespan shape skin disease and psychiatric comorbidity through the brain–skin axis and Neuro‐Immuno‐Cutaneous‐Endocrine (NICE) network. This narrative review links puberty, menstruation, pregnancy, postpartum and menopause to dermatologic and psychosocial outcomes.
Sheila Sharifi   +4 more
wiley   +1 more source

Ethics of regulating competition for women with hyperandrogenism

open access: yes, 2016
KEY POINTS1. IAAF Hyperandrogenism Regulations are flawed on a scientific level because it has not been proved that testosterone confers an advantage in competition.2.
Camporesi, Silvia
core   +1 more source

Hyperandrogenic States in Pregnancy

open access: yesPhysiological Research, 2011
Hyperandrogenic states in pregnancy are almost always the result of a condition that arises during pregnancy. The onset of virilization symptoms is often very fast. The mother is protected against hyperandrogenism by a high level of SHBG, by placental aromatase and a high level of progesterone.
N, Kaňová, M, Bičíková
openaire   +2 more sources

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D

open access: yesClinical and Experimental Obstetrics & Gynecology, 2020
Background: Polycystic ovary syndrome (PCOS) is a common condition among female of reproductive age. Vitamin D may involve in the pathogenesis of PCOS.
A. M. Maysara   +2 more
doaj   +1 more source

Ashwagandha: Is It Safe? Part 1: A Regulatory Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Over the last decade, ashwagandha (Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny by EU regulators regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No. 1925/2006 in the European Union (EU).
T. Brendler   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy